MDMAT
Entactogen drug
From Wikipedia, the free encyclopedia
MDMAT, also known as 6,7-methylenedioxy-N-methyl-2-aminotetralin, is a serotonin releasing agent (SRA) and possible entactogen of the 2-aminotetralin family. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA.[2][3] It has been theorized to have less long-term neurotoxicity and less hallucinogenic effects than other MDxx derivatives,[4] but no formal scientific research has been conducted specifically on MDMAT.
Other names6,7-MDMAT; 6,7-Methylenedioxy-N-methyl-2-aminotetralin
ATC code
- None
Legal status
- US: Uncontrolled;[1] May fall under the Federal Analogue Act
| Clinical data | |
|---|---|
| Other names | 6,7-MDMAT; 6,7-Methylenedioxy-N-methyl-2-aminotetralin |
| Drug class | Serotonin releasing agent; Entactogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H15NO2 |
| Molar mass | 205.257 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |